LCP1 was a candidate diagnostic marker for HLH, FCGR2A and CD163 were potential makers for HLH-malignancy, and C1QB was associated with disease severity (thus helping to predict MODS and early death in patients with HLH). Here, CD163 is linked to hemophagocytic syndrome.